Franziska Michor
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Franziska Michor
Franziska Michor was last confirmed as Board Member at Recursion Pharmaceuticals, Inc. (RXRX) in a filing dated April 28, 2025. Recursion Pharmaceuticals, Inc. reported in an 8-K filed November 20, 2024 that Franziska Michor was appointed Class II Director, effective November 20, 2024.
“Effective as of the Effective Time, in connection with Exscientia's right to designate one member of the board of directors of Exscientia to serve as a member of the Board under the terms of the Transaction Agreement, the Board increased the number of members of the Board from 7 to 8 and appointed Franziska Michor, Ph.D., ("Dr. Michor") as a Class II Director of the Board, with her initial term to extend until the 2026 Annual Meeting of Stockholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2024-01-01–2025-04-28
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.